• Home
  • Media
  • Sitemap
  • About Us
    • The company
      • Brief Profile
      • Vision
      • Mission 2013
      • Key Milestones
      • Board of Directors
      • Key Management Team
    • Parabolic Drugs in News
    • Media Gallery
  •  Our Business
    • CRAMS
      • Infrastructure
      • Capabilities
      • Our Business Model
      • Why PDL?
      • Contact CRAMS Division
    • APIs
      • Segments
      • Manufacturing Facilities
      • Our Products
      • Accreditations
      • Contact us for APIs
    • R & D
      • R&D Centre, Barwala
      • R&D Lab, Derabassi
      • IPR,QA & QC
  •  Global Presence
    • Market Presence
    • Regulatory Affairs
    • Business Opportunities
      • Contract Research
      • Contract manufacturing
      • Strategic tieups for Global Marketing
  • Human Resources
    • HR at PDL
      • HR Vision
      • HR Goals
    • Work with us
      • Current Openings
      • Upload your CV
  • CSR
    • CSR Initiatives
    • Environmental Concern
    • Health and Safety
  • Investor Relations
    • MD's Address
    • Corporate Governance
    • latest Financial Results
    • Key Financial Indicators
    • Share Holding Pattern
    • Annual Reports
    • Track PDL's Share
    • Research Reports on PDL
    • Contact IR
  • Contact us

Analyst Corner- Research Reports on PDL


The Following is the list of coverage for Parabolic Drugs Limited from different analysts

 

Research House Analyst Name Download Link
India Infoline(IIFL) Amar Ambani/Akash Jain IIFL Research
Avendus- India Equity Research Monika Joshi Avendus Research

 



Disclaimer

Parabolic Drugs Limited has no relations with any of these institutions and makes no recommendations about any of these brokerage houses or institutions.

We do not claim any responsibility to the research reports published by the brokerage houses and institutions and is an independent assessment by those brokerage houses and institutions. It is not intended to be a recommendation for financial investment in the company, but should be considered as a service that we offer for our readers and shareholders' convenience.

 


Go Back | Home




Parabolic Drugs Limited © 2010 | About Us | Contact us | Sitemap |
Privacy Policy